Sera Prognostics (SERA) Form 3: CMO reports no holdings
Sera Prognostics (SERA) filed a Form 3 initial statement for its Chief Medical Officer, indicating the officer’s relationship to the company and reporting no securities beneficially owned as of the event date 10/01/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sera Prognostics (SERA) filed a Form 3 initial statement for its Chief Medical Officer, indicating the officer’s relationship to the company and reporting no securities beneficially owned as of the event date 10/01/2025. The filing was submitted as an individual report and includes an Exhibit 24.1 Power of Attorney authorizing the attorney-in-fact to sign on the reporting person’s behalf. This is a routine ownership disclosure required at the start of insider reporting.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Sera Prognostics (SERA) file?
Who is the reporting person and role?
What is the event date on the Form 3 for SERA?
Does the reporting person own SERA securities?
Is this an individual or joint filing?
What additional document is referenced?
AI-generated analysis. How Rhea-AI works. Not financial advice.